ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Jie Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8196-0454; OpenAlex author ID A5100659923. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper

Papers 1

The spatial coexistence of TIGIT/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic ductal adenocarcinoma. Last author DOI 10.7150/thno.86547 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xianlong Chen · 1 shared paper, 2023 · strength 0.18
- Paper The spatial coexistence of TIGIT/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic du… DOI 10.7150/thno.86547 ↗
Shuangni Yu · 1 shared paper, 2023 · strength 0.18
- Paper The spatial coexistence of TIGIT/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic du… DOI 10.7150/thno.86547 ↗
Heng Ma · 1 shared paper, 2023 · strength 0.18
- Paper The spatial coexistence of TIGIT/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic du… DOI 10.7150/thno.86547 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.